As of 05 Nov 2026 06:27 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from the latest notice (09 Apr 2021): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Haloperidol 5mg/5ml oral solution sugar free (Thame Laboratories)affected product · inferred from phrasing | Out of stock, as stated | March 2021precision: a month · window end 31 Mar 2021, derived from “March 2021” | notice of 09 Apr 2021 |
| Haloperidol 500microgram, 1.5mg, 5mg and 10mg tabletsnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 09 Apr 2021 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register — 1 earlier protocol on this record has expired: SSP004 (to 23 Mar 2020). Matching is by name until identifier coding lands.
Named in the source as remaining available
- Haloperidol 500microgram, 1.5mg, 5mg and 10mg tablets — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Haloperidol
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 09 Apr 2021. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 09 Apr 2021 | Medicine Supply Notification: Haloperidol 5mg/5ml oral solution sugar free (Thame Laboratories) - Update | Supply notification | — | — |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2020)110 Haloperidol 5mg/5ml oral solution sugar free (Thame Laboratories) · issued 09 Nov 2020 · valid until March 2021, as stated · matched by name PDF ↗
- MSAN(2019)27 Haloperidol (Serenace®) 500 microgram capsules (Teva) · issued 18 Dec 2019 · valid until Date to be determined, as stated · matched by name PDF ↗